Attached files
| file | filename |
|---|---|
| 10-K/A - 10-K/A - GLOBEIMMUNE INC | gbim-10ka_20151231.htm |
| EX-31.2 - EX-31.2 - GLOBEIMMUNE INC | gbim-ex312_8.htm |
| EX-32.2 - EX-32.2 - GLOBEIMMUNE INC | gbim-ex322_6.htm |
| EX-31.1 - EX-31.1 - GLOBEIMMUNE INC | gbim-ex311_9.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of GlobeImmune, Inc. (the “Company”) on Form 10-K/A for the period ending December 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
|
|
(1) |
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
|
Date: April 28, 2016 |
|
By: |
|
/s/ Timothy C. Rodell |
|
|
|
|
|
Timothy C. Rodell, M.D. |
|
|
|
|
|
Chief Executive Officer and President |
The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350, is not being "filed" by the Company as part of the Report or as a separate disclosure document and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Report), irrespective of any general incorporation language contained in such filing.